Platelet-Rich Plasma Treatment for Chronic Respiratory Disease

This study was conducted to test the hypothesis that platelet-rich plasma (PRP) therapy in chronic respiratory disease patients will cause lung regeneration, thereby slowing the progression of the disease. We performed a search to obtain pertinent articles on the following electronic databases: Goog...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Aaron D, Kacker, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891651/
https://www.ncbi.nlm.nih.gov/pubmed/36741673
http://dx.doi.org/10.7759/cureus.33265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891651/
https://www.ncbi.nlm.nih.gov/pubmed/36741673
http://dx.doi.org/10.7759/cureus.33265

Ejemplares similares